# Vaccine Therapy in Treating Patients With Kidney Cancer

> **NCT00014131** · PHASE1 · TERMINATED · sponsor: **Lisata Therapeutics, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **BIOLOGICAL:** Biological/Vaccine: therapeutic autologous dendritic cells.

## Key facts

- **NCT ID:** NCT00014131
- **Lead sponsor:** Lisata Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** change in corporate priorities
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014131, "Vaccine Therapy in Treating Patients With Kidney Cancer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00014131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*